Clinical trial
Measuring the Effects of Medication and Behavioral Treatments for Challenging Behavior
NCT07024303 is registered in ClinicalTrials.gov with Matthew J O'Brien, PhD, BCBA-D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Measuring the Effects of Medication and Behavioral Treatments for Challenging Behavior
- Lead sponsor
- Matthew J O'Brien, PhD, BCBA-D
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- June 15, 2025
- Completion date
- December 31, 2027
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
autism spectrum disorder, challenging behavior